Solesence Inc Dossier - Source-backed chat

Solesence Inc

SLSNNASDAQ

SectorMaterials

IndustrySpecialty Chemicals

Beta (adjusted)1.12

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $0.83Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $58.9M

Enterprise Value $71.4M

Shares Outstanding 70.7M diluted

Next Earnings Date16 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Solésence, Inc. (formerly Nanophase Technologies Corporation) has successfully transitioned its business model to focus on mineral-based skin care, sun care, and color cosmetics technologies. While the company's proprietary Active Stress Defense platform (including Kleair) and newly launched WHSPR and Chromalüm technologies offer strong competitive advantages in the OTC-grade mineral beauty market, near-term performance is pressured by shipment delays and high operating costs. A Hold recommendation is warranted as the market digests the Q1 2026 swing to a loss and monitors the commercial scaling of its new technology platforms.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Base CaseCentral scenario

$1.50

Solésence steadily resolves its shipment delays and supply chain bottlenecks, stabilizing quarterly revenue around $15M-$16M while maintaining a modest operating profit as its brand partners scale.

Bull CaseUpside scenario

$2.00

Rapid commercial adoption of WHSPR and Chromalüm platforms by major prestige beauty brands drives high-margin royalty and manufacturing revenue, expanding gross margins back toward historical highs.

Scenarios reflect our research view at the research date.

Key Investment Merits

Proprietary, patent-protected Active Stress Defense and Kleair technology suites providing market-leading transparency and aesthetics in mineral sunscreens.
WHSPR platform enables high-concentration allantoin delivery in anhydrous formats, unlocking new OTC-grade sensitive skin claims for brand partners.
Established B2B relationships with dozens of leading global and indie beauty brands, acting as a key contract manufacturing partner.

Key Investment Risks

Dependence on a limited number of key customers.
Deteriorating financial position marked by recent revenue decline and net loss.
High operating costs relative to the current scale of operations, limiting near-term operating margin expansion.

Thesis Invalidation Triggers

Loss of major brand partners representing more than 15% of total contract manufacturing revenue.
Failure of WHSPR or Chromalüm technologies to secure commercial contracts within the next 12 months.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.